Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors
Clinical trial NCT06082960 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06082960
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-09
- Primary completion
- 2026-12-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.